Ramzi Benamar

Ramzi Benamar currently serves as the Chief Financial Officer at Apnimed since October 2024. Prior to this role, Benamar held the position of Chief Financial Officer at Elucida Oncology, Inc. from August 2023 to June 2024 and at Bellus Health from December 2020 until its acquisition by GSK in July 2023. Additional experience includes serving as Chief Financial Officer at DBV Technologies in early 2020 and as Head/Vice President of Financial Planning & Analysis and Finance Business Partnering at Spark Therapeutics, Inc. from January 2017 to January 2020, prior to its acquisition by Roche Holding AG. Ramzi Benamar holds both a Bachelor and Master of Business Administration from Temple University and a Master’s degree from the University of the Sciences in Philadelphia.